ARC
DEAD

Serial Number

87574584

Owner

Shattuck Labs, Inc.

Attorney

Christopher M. Kindel

Filing Date

Aug 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ARC Trademark

Serial Number: 87574584

ARC is a trademark filed by Shattuck Labs, Inc. on August 18, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Shattuck Labs, Inc. (5 trademarks)

Austin, TX 78701

Entity Type: 03

Trademark Details

Filing Date

August 18, 2017

Registration Date

Not Registered

Published for Opposition

November 20, 2018

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammatory disease; pharmaceutical preparations, namely, bi-specific fusion proteins for medical diagnostic purposes; biological preparations for the treatment of inflammatory disease; pharmaceutical products for the prevention of cancer and the prevention and treatment of inflammatory disease; synthetic peptides for the treatment of inflammatory disease; vaccine preparations; none of the foregoing goods are for veterinary purposes, and none of the foregoing in connection with either medicated topical creams for treating radiation dermatitis or medicated skin care preparations for protecting skin

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and inflammatory disease; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, development of pharmaceutical preparations in the form of cancer immunotherapy proteins for use in manufacturing therapeutics; None of the foregoing services are for veterinary purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 3, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 3, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2022 EXRA
SOU EXTENSION 5 GRANTED
Aug 24, 2022 EX5G
SOU EXTENSION 5 FILED
Aug 18, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2022 EXRA
SOU EXTENSION 4 GRANTED
Feb 23, 2022 EX4G
SOU EXTENSION 4 FILED
Feb 23, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 23, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2021 EXRA
SOU EXTENSION 3 GRANTED
Aug 17, 2021 EX3G
SOU EXTENSION 3 FILED
Aug 17, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 17, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 10, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 10, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2021 EXRA
SOU EXTENSION 2 GRANTED
Feb 18, 2021 EX2G
SOU EXTENSION 2 FILED
Feb 18, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 18, 2021 EEXT
CORRECTED NOA E-MAILED
Oct 7, 2020 NOAC
DIVISIONAL PROCESSING COMPLETE
Oct 6, 2020 DPCC
RESPONSE TO ITU OFFICE ACTION ENTERED
Oct 5, 2020 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2020 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Sep 29, 2020 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 28, 2020 AITU
DIVISIONAL REQUEST RECEIVED
Sep 11, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 11, 2020 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2020 EXRA
SOU EXTENSION 1 GRANTED
Aug 24, 2020 EX1G
SOU EXTENSION 1 FILED
Aug 24, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 24, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 30, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2020 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jan 10, 2020 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 10, 2020 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 10, 2020 OP.D
OPPOSITION INSTITUTED NO. 999999
May 17, 2019 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 19, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 31, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 27, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 27, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 30, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 28, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 28, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 28, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 23, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2017 NWOS
NEW APPLICATION ENTERED
Aug 22, 2017 NWAP